Lv11
90 积分 2025-09-17 加入
IL-2: The First Effective Immunotherapy for Human Cancer
42分钟前
待确认
Bispecific and multispecific antibodies in oncology: opportunities and challenges
2小时前
已完结
Natural killer cells in antitumour adoptive cell immunotherapy
2个月前
已完结
Chimeric Antigen Receptor Therapy
2个月前
已完结
Genetic engineering of T cells for immunotherapy
2个月前
已完结
Natural killer cells in antitumour adoptive cell immunotherapy
2个月前
已完结
Natural killer cells in antitumour adoptive cell immunotherapy
2个月前
已完结
A Interacting Model: How TRIM21 Orchestrates with Proteins in Intracellular Immunity
3个月前
已完结
Engineering IL-2 for immunotherapy of autoimmunity and cancer
5个月前
已完结
Assessing the toxicity of bispecific antibodies
5个月前
已完结
皖公网安备34019202002308
